Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.

Kudo K, Kojima S, Tabuchi K, Yabe H, Tawa A, Imaizumi M, Hanada R, Hamamoto K, Kobayashi R, Morimoto A, Nakayama H, Tsuchida M, Horibe K, Kigasawa H, Tsukimoto I; Japanese Childhood AML Cooperative Study Group.

J Clin Oncol. 2007 Dec 1;25(34):5442-7.

PMID:
18048827
2.

Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.

Gamis AS.

Pediatr Blood Cancer. 2005 Jan;44(1):13-20. Review.

PMID:
15534881
3.

Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature.

Abildgaard L, Ellebaek E, Gustafsson G, Abrahamsson J, Hovi L, Jonmundsson G, Zeller B, Hasle H.

Ann Hematol. 2006 May;85(5):275-80. Epub 2006 Mar 4. Review.

PMID:
16518605
4.

Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.

Simon JH, Tebbi CK, Freeman AI, Brecher ML, Green DM, Sandberg AA.

Cancer. 1987 Nov 15;60(10):2515-20. Review.

5.

Down syndrome, drug metabolism and chromosome 21.

Taub JW, Ge Y.

Pediatr Blood Cancer. 2005 Jan;44(1):33-9. Review.

PMID:
15390307
6.

Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).

Ogasawara T, Yasuyama M, Kawauchi K.

Am J Hematol. 2005 Jun;79(2):136-41. Review.

7.

Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.

Ribeiro RC, Oliveira MS, Fairclough D, Hurwitz C, Mirro J, Behm FG, Head D, Silva ML, Raimondi SC, Crist WM, et al.

Leuk Lymphoma. 1993 Jul;10(4-5):299-306. Review.

PMID:
8220128
8.

Optimizing therapy for myeloid disorders of Down syndrome.

Webb DK.

Br J Haematol. 2005 Oct;131(1):3-7. Review.

PMID:
16173956
9.

Megakaryoblastic leukemia and Down's syndrome: a review.

Zipursky A, Peeters M, Poon A.

Pediatr Hematol Oncol. 1987;4(3):211-30. Review.

PMID:
2978961
10.

Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.

Kobayashi K, Usami I, Kubota M, Nishio T, Kakazu N.

Cancer Genet Cytogenet. 2005 Apr 15;158(2):184-7. Review.

PMID:
15796967
11.
12.

Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome.

Dixon N, Kishnani PS, Zimmerman S.

Am J Med Genet C Semin Med Genet. 2006 Aug 15;142C(3):149-57. Review.

PMID:
17048354
13.

Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.

Webb DK, Passmore SJ, Hann IM, Harrison G, Wheatley K, Chessells JM.

Br J Haematol. 2002 Apr;117(1):33-9. Review.

PMID:
11918530
14.

Acute megakaryoblastic leukemia in Down syndrome.

Hitzler JK.

Pediatr Blood Cancer. 2007 Dec;49(7 Suppl):1066-9. Review.

PMID:
17943965
15.

Unique clinical and biological features of leukemia in Down syndrome children.

Xavier AC, Ge Y, Taub J.

Expert Rev Hematol. 2010 Apr;3(2):175-86. doi: 10.1586/ehm.10.14. Review.

PMID:
21083461
16.

Transient leukemia in newborns with Down syndrome.

Massey GV.

Pediatr Blood Cancer. 2005 Jan;44(1):29-32. Review.

PMID:
15558701
17.

[Acute megakaryoblastic leukemia in early childhood; report of two cases].

Morioka Y, Sugimoto T, Imashuku S, Matsumura T, Todo S, Nagai T, Koike T.

Rinsho Ketsueki. 1988 Feb;29(2):214-20. Review. Japanese. No abstract available.

PMID:
2968473
18.

Down syndrome and acute lymphoblastic leukaemia.

Whitlock JA.

Br J Haematol. 2006 Dec;135(5):595-602. Epub 2006 Oct 10. Review.

PMID:
17054672
20.

Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.

Vyas P, Roberts I.

Early Hum Dev. 2006 Dec;82(12):767-73. Epub 2006 Oct 24. Review.

PMID:
17064858

Supplemental Content

Support Center